Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Wenshen Yiqi Granules for airway hypersecretion in COPD
ChiCTR2000039057Phase 4Recruiting
- Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Wenshen Yiqi in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by The Second Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoints: TNF-α, IL-8 and 2 more. Started Oct 2020; status: recruiting.
02
Drugs
Wenshen Yiqi
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2000039057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039057.